A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
Clinical trial NCT02794792 · COMPLETED
Trial details
- NCT number
- NCT02794792
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-11
- Primary completion
- 2017-03-02
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.